Johnson & Johnson (BUE:JNJ) E10: ARS780.24 (As of Mar. 2026)


BUE:JNJ Johnson & Johnson BUE:JNJ
74 GF Score
Price ARS26,660.00
GF Value ARS19,653.38
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson E10?

Johnson & Johnson BUE:JNJ +1.83% 74 E10 is ARS780.24 as of Mar. 2026. GuruFocus rates BUE:JNJ with a GF Score™ of 74/100 and a GF Value™ of ARS19,653.38 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2026 was ARS598.449. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ARS780.24 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Johnson & Johnson's average E10 Growth Rate was 4.60% per year. During the past 3 years, the average E10 Growth Rate was 7.60% per year. During the past 5 years, the average E10 Growth Rate was 9.20% per year. During the past 10 years, the average E10 Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Johnson & Johnson was 15.60% per year. The lowest was -0.10% per year. And the median was 9.10% per year.

As of today (2026-06-30), Johnson & Johnson's current stock price is ARS26660.00. Johnson & Johnson's E10 for the quarter that ended in Mar. 2026 was ARS780.24. Johnson & Johnson's Shiller PE Ratio of today is 34.17.

During the past 13 years, the highest Shiller PE Ratio of Johnson & Johnson was 33.32. The lowest was 19.57. And the median was 26.85.


Johnson & Johnson  (BUE:JNJ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26660.00/780.24
=34.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Johnson & Johnson was 33.32. The lowest was 19.57. And the median was 26.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Johnson & Johnson E10 Related Terms


Johnson & Johnson E10 Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson E10 Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 233.91 143.64 467.48 568.52 794.66

Johnson & Johnson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 668.81 622.19 799.50 794.66 780.24

BUE:JNJ vs ABBV, MRK, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.


BUE:JNJ
74GF Score
Johnson & Johnson BUE:JNJ
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=598.449/330.2130*330.2130
=598.449

Current CPI (Mar. 2026) = 330.2130.

Johnson & Johnson Quarterly Data

per share eps CPI Adj_EPS
201606 3.998 241.018 5.478
201609 4.565 241.428 6.244
201612 4.375 241.432 5.984
201703 4.964 243.801 6.723
201706 4.617 244.955 6.224
201709 4.801 246.819 6.423
201712 -15.238 246.524 -20.411
201803 6.448 249.554 8.532
201806 7.233 251.989 9.478
201809 10.598 252.439 13.863
201812 8.446 251.233 11.101
201903 10.867 254.202 14.116
201906 18.586 256.143 23.961
201909 7.382 256.759 9.494
201912 17.932 256.974 23.043
202003 26.938 258.115 34.462
202006 18.621 257.797 23.852
202009 19.748 260.280 25.054
202012 10.579 260.474 13.411
202103 41.797 264.877 52.107
202106 44.523 271.696 54.112
202109 26.792 274.310 32.252
202112 35.750 278.802 42.342
202203 41.446 287.504 47.603
202206 43.319 296.311 48.275
202209 46.687 296.808 51.942
202212 44.595 296.797 49.616
202303 -1.185 301.836 -1.296
202306 94.080 305.109 101.821
202309 714.598 307.789 766.660
202312 120.574 306.746 129.798
202403 225.790 312.332 238.716
202406 345.663 314.175 363.308
202409 211.011 315.301 220.991
202412 284.820 315.605 298.003
202503 967.962 319.799 999.483
202506 543.753 322.561 556.652
202509 575.797 324.800 585.393
202512 609.625 324.054 621.212
202603 598.449 330.213 598.449

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ARS780.24 mean?
Johnson & Johnson (BUE:JNJ) has a E10 of ARS780.24 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's E10 too high?
Johnson & Johnson's current E10 is ARS780.24. Overall, Johnson & Johnson has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's E10 compare to ABBV and MRK?
Johnson & Johnson's E10 of ARS780.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current E10 is ARS780.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (BUE:JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS19,653.38, compared to a current price of ARS26,660.00 — trading 35.7% above its estimated fair value. The current E10 is ARS780.24. Johnson & Johnson's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Johnson & Johnson (BUE:JNJ), the current E10 is ARS780.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (BUE:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of ARS26,660.00 is trading 35.7% above its estimated GF Value™ of ARS19,653.38. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for BUE:JNJ:

  • E10: ARS780.24
  • GF Value™: ARS19,653.38 vs. price of ARS26,660.00 (35.7% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the BUE:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
74GF Score

Get the complete analysis for BUE:JNJ

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS26,660.00
Price
ARS19,653.38
GF Value